Lancaster Opens $7 Million Position in 10x Genomics (TXG)

On October 8, 2025, Lancaster Investment Management disclosed a new position in 10x Genomics (NASDAQ:TXG). It opened its position in the single cell research company with the acquisition of around $7.27 million in shares.According to a filing with the Securities and Exchange Commission dated October 8, 2025, Lancaster Investment Management established a new position in 10x Genomics during the third quarter. The fund reported owning 621,779 shares at quarter-end, valued at $7.27 million.This was a new position for Lancaster, representing 3.1% of its 13F reportable assets under management as of September 30, 2025.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool